Holen Sie sich die Stockscreener-App
2.66
2.21%
-0.06
Handel nachbörslich:
2.79
0.13
+4.89%
Schlusskurs vom Vortag:
$2.72
Offen:
$2.7
24-Stunden-Volumen:
423.28K
Relative Volume:
1.40
Marktkapitalisierung:
$102.79M
Einnahmen:
$2.76M
Nettoeinkommen (Verlust:
$-49.12M
KGV:
-1.7733
EPS:
-1.5
Netto-Cashflow:
$-46.21M
1W Leistung:
+0.76%
1M Leistung:
-8.90%
6M Leistung:
-52.50%
1J Leistung:
-55.37%
1-Tages-Spanne:
$2.58
$2.74
1-Wochen-Bereich:
$2.50
$2.78
52-Wochen-Spanne:
$2.37
$7.04
Orchestra Biomed Holdings Inc Stock (OBIO) Company Profile
Firmenname
Orchestra Biomed Holdings Inc
Sektor
Branche
Telefon
646-343-9298
Adresse
150 UNION SQUARE DRIVE, NEW HOPE
Vergleichen Sie OBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OBIO
Orchestra Biomed Holdings Inc
|
2.66 | 146.75M | 2.76M | -49.12M | -46.21M | -1.50 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Orchestra Biomed Holdings Inc Stock (OBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-20 | Eingeleitet | BTIG Research | Buy |
| 2025-01-02 | Eingeleitet | Barclays | Overweight |
| 2024-08-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-07-25 | Eingeleitet | B. Riley Securities | Buy |
| 2024-01-19 | Eingeleitet | Jefferies | Buy |
| 2023-02-24 | Eingeleitet | Piper Sandler | Overweight |
| 2023-02-07 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Orchestra Biomed Holdings Inc Aktie (OBIO) Neueste Nachrichten
Detecting support and resistance levels for Orchestra BioMed Holdings Inc.Weekly Trend Report & Accurate Intraday Trading Signals - Newser
Reversal indicators forming on Orchestra BioMed Holdings Inc. stock2025 Top Gainers & Scalable Portfolio Growth Methods - Newser
Is a relief rally coming for Orchestra BioMed Holdings Inc. holdersPortfolio Update Report & Real-Time Chart Pattern Alerts - Newser
Signal strength of Orchestra BioMed Holdings Inc. stock in tech scannersWeekly Profit Analysis & Free High Accuracy Swing Entry Alerts - Newser
FDA Greenlights Broader Patient Access for AVIM Therapy Trial in Pacemaker Patients - MSN
Advanced analytics toolkit walkthrough for Orchestra BioMed Holdings Inc.July 2025 Momentum & Stepwise Entry/Exit Trade Alerts - Newser
Why Orchestra BioMed Holdings Inc. is moving todayRate Cut & AI Enhanced Trading Signals - Newser
How to integrate Orchestra BioMed Holdings Inc. into portfolio analysis toolsMarket Trend Review & High Conviction Buy Zone Alerts - Newser
What the charts say about Orchestra BioMed Holdings Inc. today [Quarterly Portfolio Report]Daily Chart Pattern Signals - Newser
What data driven models say about Orchestra BioMed Holdings Inc.’s future [Day Trade] - Newser
Can Orchestra BioMed Holdings Inc. hit a new high this monthJuly 2025 Price Swings & Fast Entry Momentum Trade Alerts - Newser
Best data tools to analyze Orchestra BioMed Holdings Inc. stockDaily Trade Setup Forecast with Confidence - Newser
Can you recover from losses in Orchestra BioMed Holdings Inc.Free Weekly Chart Analysis With Entry Advice - Newser
Why Orchestra BioMed Holdings Inc. stock attracts strong analyst attentionProfit Target & Verified Stock Trade Ideas - Newser
Should you wait for a breakout in Orchestra BioMed Holdings Inc.Free Low Drawdown Real Time Trading Tips - Newser
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Orchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates - GlobeNewswire
Orchestra BioMed Lands $111M Strategic Investment and FDA Breakthrough Status for Heart Disease Tech - Stock Titan
Orchestra BioMed Holdings, Inc. SEC 10-Q Report - TradingView
Will Orchestra BioMed Holdings Inc. continue its uptrendSafe and Scalable Return Strategy Blueprint - Newser
What data driven models say about Orchestra BioMed Holdings Inc.’s futureFree AI Powered High Return Stock Calls - Newser
Does Orchestra BioMed Holdings Inc. show high probability of reboundStock Price Prediction Using AI Tools - Newser
Applying sector rotation models to Orchestra BioMed Holdings Inc.Conservative Asset Allocation Risk Analysis - Newser
Intrinsic Value of Orchestra BioMed Holdings Inc. Stock: Is It Undervalued or OvervaluedCapital Safe Picks with Consistent Gains - Newser
Orchestra BioMed Holdings Inc. stock trend outlook and recovery pathFree Pattern Detection for Entry Confirmation - Newser
Long term hold vs stop loss in Orchestra BioMed Holdings Inc.Consistent Return Setup with Exit Strategy - Newser
Is Orchestra BioMed Holdings Inc. a candidate for recovery playAnnual Market Behavior and Sector Summary - Newser
Orchestra BioMed (OBIO) Expected to Announce Earnings on Monday - Defense World
Real time pattern detection on Orchestra BioMed Holdings Inc. stockFree Weekly Top Gainers Forecast Watchlist - Newser
SEC Filings Archive 2025-08-08Historical 10-K, 10-Q, 8-K Forms - Stock Titan
Regression analysis insights on Orchestra BioMed Holdings Inc. performanceHigh Probability Trade Outcome Prediction - Newser
What MACD and RSI say about Orchestra BioMed Holdings Inc.Value Investing Summary and Earnings Outlook - Newser
Orchestra BioMed stock rises on trial update (OBIO:NASDAQ) - Seeking Alpha
Orchestra BioMed Announces Rollout of FDA-Approved BACKBEAT - GlobeNewswire
Orchestra BioMed Announces Rollout of FDA-Approved BACKBEAT Global Pivotal Study Protocol Update Significantly Expanding Patient Eligibility - Yahoo Finance
Orchestra Biomed Holdings, Inc. shares fall 2.31% after-hours following a strategic transaction and equity offering. - AInvest
Orchestra BioMed: Chardan Capital Keeps Buy Rating, PT Raised to $20. - AInvest
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Major Investment Alert: Perceptive Advisors Boosts Stake in Orchestra BioMed! - TipRanks
Orchestra BioMed Secures $111 Million - citybiz
Perceptive Advisors buys 700k Orchestra BioMed shares at $2.75 per share. - AInvest
Medtronic (MDT) Invests in Orchestra BioMed's Strategic Expansion - GuruFocus
Orchestra BioMed Secures Over $111 Million in Proceeds and Committed Capital Following Completion of Strategic Transactions and Concurrent Public and Private Equity Offerings - The Manila Times
Orchestra BioMed Raises $111.2M for AVIM Therapy Advancement - AInvest
Orchestra BioMed Secures Over $111 Million in Proceeds and - GlobeNewswire
Orchestra BioMed Secures Massive $111M Funding: Medtronic, Ligand Back Late-Stage Clinical Trials - Stock Titan
Orchestra BioMed’s CEO Makes Bold Stock Purchase! - TipRanks
Orchestra BioMed director Hochman buys $55,000 in OBIO stock By Investing.com - Investing.com Canada
Finanzdaten der Orchestra Biomed Holdings Inc-Aktie (OBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):